US equities
|
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Acurx Pharmaceuticals, Inc. - Common Stock
(NQ:
ACXP
)
1.060
+0.110 (+11.58%)
Delayed Quote
Updated: 4:00 PM EST, Nov 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Acurx Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
55 Biggest Movers From Friday
↗
June 28, 2021
Gainers IKONICS Corporation (NASDAQ: IKNX) shares surged 64.3% to close at $18.56 on Friday after the company reported a merger deal with TeraWulf. Alpha Teknova, Inc. (NASDAQ:...
Via
Benzinga
Software Startup Sprinklr Falls In Market Debut, More IPO News
↗
June 27, 2021
Shares of Sprinklr fell almost 9% in their market debut on Wednesday, valuing the startup at $3.7B. The software company counts Microsoft and Verizon as customers. Didi and Krispy Kreme are among...
Via
Talk Markets
Topics
Initial Public Offering
Acurx Pharmaceuticals Draws Interest After Morning IPO; Could Deliver First Class Of New Antibiotics Since The 1980’s (Nasdaq: ACXP)
June 25, 2021
Via
AB Newswire
Topics
Initial Public Offering
< Previous
1
2
3
4
5
6
7
8
Next >